A novel mRNA cancer vaccine helps reduce the chances of melanoma patients' tumors returning
A personalized mRNA cancer vaccine, developed by Moderna and MSD, has been shown to reduce the risk of melanoma recurrence or death by 42% when combined with pembrolizumab immunotherapy[2, 3, 5, 9]. The vaccine uses each patient's own tumor to create a personalized therapeutic cancer vaccine[2, 3, 5]. This approach has demonstrated promising results in a late-stage clinical trial[2, 3, 5, 9]. According to the trial results, the combination of the personalized vaccine and immunotherapy significantly lowered the risk of melanoma recurrence or death[2, 3, 5, 9].
This brief was written by a language model from the reports below; bracketed numbers link to them. Check the reports for anything that matters.
Reports
- A novel mRNA cancer vaccine helps reduce the chances of melanoma patients' tumors returningPublished by niagara-gazette.com, wgntv.com, myfox8.com, mychamplainvalley.com, wccbcharlotte.com, wbur.org, gjsentinel.com, mymotherlode.com, netscape.com, abcnews.com, reporterherald.com, fortmorgantimes.com and 22 more ·
- mRNA cancer vaccine helps reduce the chances of melanoma tumors returningPublished by ksbw.com, kcci.com, kmbc.com, wvtm13.com, wgal.com, wbaltv.com, wdsu.com, wapt.com, wisn.com, wlky.com, wmur.com, wmtw.com and 9 more ·
- Novel mRNA cancer vaccine helps reduce chances of melanoma patients' tumors returningPublished by abc7.com, wfla.com, abc30.com, abc7news.com, abc13.com, abc11.com, abc7ny.com, abc7chicago.com ·
- World's first mRNA cancer jab for melanoma cuts risk of death by 42%Published by newburytoday.co.uk, lynnnews.co.uk, standard.co.uk, newarkadvertiser.co.uk, dissexpress.co.uk, rutland-times.co.uk, kentonline.co.uk, aol.co.uk ·
- Australia helps develop world-first mRNA cancer vaccine for melanomaPublished by smh.com.au, theage.com.au, brisbanetimes.com.au, theage.com.au, brisbanetimes.com.au, smh.com.au ·
- An mRNA cancer vaccine helps reduce the chances of melanoma patients' tumors returningPublished by koat.com, wcvb.com, wpbf.com, wxii12.com, wesh.com ·
- World’s first mRNA cancer jab for melanoma cuts risk of death by 42%Published by independent.co.uk, irishnews.com, standard.co.uk, independent.co.uk ·
- Experimental mRNA cancer vaccine cuts risk of melanoma returning by 42%: ‘A new frontier'Published by nbcboston.com, nbcnewyork.com, nbcmiami.com, nbcchicago.com ·
- Experimental mRNA vaccine cuts risk that melanoma returns by 42%Published by wsvn.com, krdo.com, abc12.com ·
- Experimental mRNA vaccine cuts risk melanoma returns by 42%Published by wxow.com, krdo.com, channel3000.com ·
- Cancer vaccine breakthrough: Melanoma mRNA treatment set to cut recurrence by 42 per cent in world-firstPublished by theage.com.au, brisbanetimes.com.au, smh.com.au ·
- Cáncer de piel: una vacuna de ARNm redujo 42% el riesgo de recurrencia o muerte por melanomaSkin cancer: an mRNA vaccine reduced the risk of recurrence or death from melanoma by 42%Published by eldebate.com.ar, infobae.com ·
- Como funciona a vacina contra o câncer que reduz risco de recidiva ou morte por melanomaPublished by jornaldebrasilia.com.br, folha.uol.com.br ·
- Vaksina e personalizuar kundër kancerit, studimi raporton ulje me 42% të rrezikut të vdekjesPublished by tiranatoday.al, balkanweb.com ·
- Studimi i ri: Vaksina e personalizuar kundër kancerit ul me 42 për qind rrezikun e rikthimit të melanomësPublished by botasot.info, abcnews.al ·
- Studimi i ri/ Vaksina e personalizuar kundër kancerit e ul me 42 për qind rrezikun e rikthimit të melanomësPublished by 24-ore.com, javanews.al ·
- Prueba Moderna vacuna de ARNm contra el cáncer; reduce 42% el riesgo de recaídaPublished by nvinoticias.com, nvinoticias.com ·
- Personalized cancer vaccine cuts risk of melanoma recurrence or death by 42 pct: trialPublished by australianherald.com, sydneysun.com ·
- Merck, Moderna Personalized MRNA Caner Vaccine Cuts Melanoma Recurrence Risk In Phase 3 StudyPublished by finanzen.ch, rttnews.com ·
- A novel mRNA cancer vaccine helps reduce the chances of melanoma patients’ tumors returningPublished by sentinelcolorado.com, seattletimes.com ·
- Australian-led mRNA cancer vaccine trial cuts melanoma return risk by 42 per centPublished by thewest.com.au, perthnow.com.au ·
- Cancer vaccine cuts melanoma death risk by 42 per centPublished by thewest.com.au, perthnow.com.au ·
- Nova vacina promete reduzir morte por melanoma (câncer de pele)New vaccine promises to reduce melanoma deathsotempo.com.br · pt ·
- Como funciona a vacina contra o câncer que reduz risco de morte por melanomaHow the cancer vaccine that reduces the risk of death from melanoma workstribunaonline.com.br · pt ·
- Melanoma vaccine reduces death or cancer recurrence by 42%medicalxpress.com · en ·
- Moderna și Merck anunță rezultate pentru vaccinul anticancer: riscul de deces sau recidivă a melanomului a scăzut cu 42%Moderna and Merck announce results for the anticancer vaccine: the risk of death or melanoma recurrence decreased by 42%capital.ro · ro ·
- Personalised skin cancer vaccine cuts recurrence, death risk by 42%channelafrica.co.za · en ·
- New personalized cancer vaccine cuts Melanoma recurrence risk by 42%, trial showsthenews.com.pk · en ·
- Breakthrough cancer vaccine reduces melanoma from returning by 42%, data showsabcnews.com · en ·
- Personalized mRNA vaccine for melanoma cut risk of cancer's return in late-stage trialnbcnews.com · en ·
- Vacuna contra el melanoma reduce un 42 % el riesgo de recaída o muerte en un ensayonoticiassin.com · es ·
- Vaccin personalizat împotriva cancerului cu rezultate spectaculoase: reduce riscul de recidivă sau deces cu 42%. Mărturia unui participant la studiuadevarul.ro · ro ·
- Cancer vaccine reduces melanoma from returning by 42%, data showsaol.com · en ·
- mRNA vaccine reduced melanoma recurrence risk 42% after surgeryhealio.com · en ·
- Merck și Moderna anunță că vaccinul lor împotriva cancerului reduce cu 42% riscul de deces sau de recidivă în cazul melanomuluig4media.ro · ro ·
- Personalisierter mRNA-Impfstoff senkt Melanom-Rückfallrisiko deutlichaerztezeitung.de · de ·
- Personalized cancer vaccine cuts risk of melanoma recurrence or death by 42% in trialAnadolu Agency (English) · en ·
- A novel mRNA cancer vaccine helps cut the chances of melanoma tumor recurrence in major studycinaradio.com · en ·
- Нова надеж против меланомот: Персонализирана вакцина со имунотерапија го намали ризикот за 42%tocka.com.mk · mk ·
- Vaksina e personalizuar mRNA redukton me 42% rrezikun e rikthimit të melanomësalbeu.com · sq ·
- Vacina de mRNA contra câncer reduz em 42% risco de morte ou volta do melanomajaenoticia.com.br · pt ·
- World-first personalised cancer jab cuts risk of melanoma returning or death by 42% in major triallbc.co.uk · en ·
- Kişiye özel mRNA aşısı melanomda nüks veya ölüm riskini yüzde 42 azalttımedimagazin.com.tr · tr ·
- Novel mRNA cancer vaccine developed by Cambridge drugmaker helps keep melanoma tumors at baywgbh.org · en ·
- Melanoma il vaccino a mRNA personalizzato riduce del 42% il rischio di recidiva o mortezazoom.it · it ·
- Melanoma il vaccino a mRna riduce del 42% i rischi di recidivazazoom.it · it ·
- Melanoma, “il vaccino a mRNA personalizzato riduce del 42% il rischio di recidiva o morte”siftrss.com · it ·
- 复发风险降42%！首个mRNA癌症疫苗冲刺上市ifeng.com · zh ·
- Vacina contra câncer: dados mostram redução de risco no melanomauol.com.br · pt ·
- Melanoom: mRNA-middel verkleint kans op terugkeer kankertpo.nl · nl ·
- mRNA cancer vaccine cuts risk of melanoma returning by 42%: Study – NBC10 Philadelphianbcphiladelphia.com · en ·
- mRNA cancer vaccine cuts risk of melanoma returning by 42%: Study – NBC Bay Areanbcbayarea.com · en ·
- mRNA cancer vaccine cuts risk of melanoma returning by 42%: Study – NBC4 Washingtonnbcwashington.com · en ·
- mRNA cancer vaccine cuts risk of melanoma returning by 42%: Study – NBC Los Angelesnbclosangeles.com · en ·
- mRNA cancer vaccine cuts risk of melanoma returning by 42%: Study – NBC 5 Dallas-Fort Worthnbcdfw.com · en ·
- mRNA cancer vaccine cuts risk of melanoma returning by 42%: Study – NBC Connecticutnbcconnecticut.com · en ·
- mRNA cancer vaccine cuts risk of melanoma returning by 42%: Study – NBC 7 San Diegonbcsandiego.com · en ·
- Vacina de mRNA contra câncer reduz em 42% risco de morte ou volta do mglobo.com · pt ·
- Melanoma, il vaccino a mRna riduce del 42% i rischi di recidivalapresse.it · it ·
- Vacina personalizada contra o câncer reduz em 42% risco de morte ou recaídajmonline.com.br · pt ·
- La vacuna personalizada contra el cáncer reduce más de 40% el riesgo de muertelavanguardia.com · es ·
- Personalized cancer vaccine cuts risk of melanoma recurrence or death by 42 pct: trial-Xinhuaenglish.news.cn · en ·
- mRNA 癌症疫苗将死亡复发风险减少 42%solidot.org · zh ·
- لقاح شخصي يُقلّل عودة سرطان "الميلانوما" بنسبة 42%annahar.com · ar ·
- First-of-its-kind cancer vaccine helps reduce chances of melanoma patients’ tumors returning: studynypost.com · en ·
- جو 24 : لقاح جديد يقلل خطر عودة الأورام لدى مرضى سرطان الجلدjo24.net · ar ·
- Vaccine reduces melanoma recurrence in trialabc.net.au · en ·
- Cancer: Experimental mRNA Vaccine Reduces Risk of Death or Melanoma Recurrence by 42%inewsgr.com · en ·
- Experimental cancer vaccine cuts melanoma recurrence risk by 42%: Studyindianexpress.com · en ·
- لقاح جديد يقلل عودة الأورام لمرضى سرطان الجلدalbayan.ae · ar ·
- Vacuna personalizada contra el cáncer reduce 42% el riesgo de recaída o muerte por melanomatermometroenlinea.com.mx · es ·
- Experimental cancer vaccine reduces melanoma death or recurrence risk by 42%geo.tv · en ·
- Moderna Aktie: Krebsimpfung senkt Rückfallrisiko um 42 Prozentboerse-express.com · de ·
- Vacina contra câncer reduz morte ou recidiva de melanoma - 22/10/2026 - Equilíbrio e SaúdeCancer vaccine reduces death or melanoma recurrenceuol.com.br · pt ·
- لقاح جديد يقلل خطر عودة الأورام لدى مرضى سرطان الجلدNew vaccine reduces risk of tumor recurrence in melanoma patientsrtarabic.com · ar ·
- Novel mRNA cancer vaccine helps reduce chances of melanoma patients' tumours returningprod-qt-images.s3.amazonaws.com · en ·
- Vacina contra câncer reduz em 42% risco de morte ou recidiva de melanomafolha.uol.com.br · pt ·
- Vacuna contra el cáncer reduce 42% riesgo de recaída o muerte; beneficio es menor al observado antesCancer vaccine reduces 42% risk of relapse or death; benefit is less than previously observedexcelsior.com.mx · es ·
- Moderna mRNA vaccine almost halves the risk of skin cancer returningnature.com · en ·
- A Personalized Cancer Vaccine Lowers Melanoma Recurrence by 42%time.com · en ·
- A novel mRNA cancer vaccine helps reduce the chances of melanoma patients' tumors returning - Boston News, Weather, Sportswhdh.com · en ·
- Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42%arstechnica.com · en ·
- Una vacuna experimental de ARNm reduce en un 42 % el riesgo de reaparición del melanomakrdo.com · en ·
- Novel mRNA cancer vaccine reduces chances of patients' tumors returningchicagotribune.com · en ·
- Vaccine reduces risk of melanoma recurrence, death by 42%: What to knowbeckershospitalreview.com · en ·
- A novel mRNA cancer vaccine helps reduce the chances of melanoma patients' tumors returning – Winnipeg Free Presswinnipegfreepress.com · en ·
- Merck, Moderna Cancer Vaccine Cuts Melanoma Recurrence Risk by 42%ajmc.com · en ·
- Vacina contra câncer reduz em 42% risco de morte ou recorrência de melanomar7.com · pt ·
- mRNA cancer vaccine slashes melanoma death or recurrence risk by 42%independent.co.uk · en ·